Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A commo...
Saved in:
Published in | Gene therapy Vol. 6; no. 2; pp. 293 - 299 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.02.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A common method for vector production involves large-scale transient transfection of multiple plasmids into cultured cells. Because this approach might not be feasible for clinical scale manufacturing, we have sought approaches for rAAV vector production that avoid transient transfection procedures. In previously reported work, we generated an AAV packaging cell line that produces infectious rAAV when the vector genome is transfected into the cell line as plasmid DNA. We have now extended this approach by constructing a hybrid recombinant adenovirus (rAd) that contains a complete rAAV vector genome in the E1 region. This hybrid virus is used to deliver the rAAV genome to the packaging cell line (in the place of plasmid transfection). rAAV is produced when the packaging cell line is infected with the hybrid adenovirus and wild-type adenovirus. This method avoids the need for plasmid transfection and is adaptable to large-scale manufacturing processes. |
---|---|
AbstractList | Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A common method for vector production involves large-scale transient transfection of multiple plasmids into cultured cells. Because this approach might not be feasible for clinical scale manufacturing, we have sought approaches for rAAV vector production that avoid transient transfection procedures. In previously reported work, we generated an AAV packaging cell line that produces infectious rAAV when the vector genome is transfected into the cell line as plasmid DNA. We have now extended this approach by constructing a hybrid recombinant adenovirus (rAd) that contains a complete rAAV vector genome in the E1 region. This hybrid virus is used to deliver the rAAV genome to the packaging cell line (in the place of plasmid transfection). rAAV is produced when the packaging cell line is infected with the hybrid adenovirus and wild-type adenovirus. This method avoids the need for plasmid transfection and is adaptable to large-scale manufacturing processes. Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A common method for vector production involves large-scale transient transfection of multiple plasmids into cultured cells. Because this approach might not be feasible for clinical scale manufacturing, we have sought approaches for rAAV vector production that avoid transient transfection procedures. In previously reported work, we generated an AAV packaging cell line that produces infec- tious rAAV when the vector genome is transfected into the cell line as plasmid DNA. We have now extended this approach by constructing a hybrid recombinant adenovirus (rAd) that contains a complete rAAV vector genome in the E1 region. This hybrid virus is used to deliver the rAAV genome to the packaging cell line (in the place of plasmid transfection). rAAV is produced when the packaging cell line is infected with the hybrid adenovirus and wild-type adenovirus. This method avoids the need for plasmid transfection and is adaptable to large-scale manufacturing processes. |
Author | CLARK, K. R LIU, X. L JOHNSON, P. R |
Author_xml | – sequence: 1 givenname: X. L surname: LIU fullname: LIU, X. L organization: Children's Hospital Research Foundation, Department of Pediatrics, Columbus, OH, United States – sequence: 2 givenname: K. R surname: CLARK fullname: CLARK, K. R organization: Children's Hospital Research Foundation, Department of Pediatrics, Columbus, OH, United States – sequence: 3 givenname: P. R surname: JOHNSON fullname: JOHNSON, P. R organization: Children's Hospital Research Foundation, Department of Pediatrics, Columbus, OH, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1721166$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10435114$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0U2LFDEQBuAgK-7s6tGrBBRvPaaSTNI5yuIXLOhBz6E6nR4z9iRjqntx_709zoCiB08pyMNLFe8Vu8glR8aegliDUO0r2q2301opIVphH7AVaGuajTbygq2EM66xINtLdkW0E0Jo28pH7BKEVhsAvWI_PtXSz2FKJfMy8BpD2XcpY5449jGXBolKSDjFnt-lOhO_i2EqlfhMKW858gOGb7g9ziGOIx9Tjhxzv_x8ve9q6v_N_JXzmD0ccKT45Pxesy9v33y-ed_cfnz34eb1bROUtVOjtQGFoIzuOotOWtdJLVrXSzUM0qo2oOwGAES9USii62EjUDrXdiYYa9Q1e3nKPdTyfY40-X2i46aYY5nJG-eUM_r_ECw4Zd0RPv8L7spc83KEl2bZV2rZ2kU1JxVqIapx8Iea9ljvPQh_bM7Tzm8nf25u8c_OqXO3j_0f-lTVAl6cAVLAcaiYQ6LfzkoAY9RPD1ujbw |
CitedBy_id | crossref_primary_10_1038_s41392_021_00487_6 crossref_primary_10_1016_S0166_0934_01_00298_1 crossref_primary_10_1016_S0264_410X_02_00074_9 crossref_primary_10_1016_S0958_1669_00_00080_X crossref_primary_10_1089_hum_2009_125 crossref_primary_10_1016_S0001_4079_19_33510_1 crossref_primary_10_1016_S1046_2023_02_00228_1 crossref_primary_10_1002_biot_202400051 crossref_primary_10_1016_j_omtm_2021_12_006 crossref_primary_10_1089_hum_2009_092 crossref_primary_10_1128_JVI_74_22_10381_10389_2000 crossref_primary_10_1097_00002030_200100005_00018 crossref_primary_10_1089_hum_2005_16_551 crossref_primary_10_1128_JVI_79_1_193_201_2005 crossref_primary_10_1038_nri776 crossref_primary_10_1002_jgm_542 crossref_primary_10_1006_mthe_2001_0306 crossref_primary_10_1006_mthe_2000_0132 crossref_primary_10_1038_mi_2016_16 crossref_primary_10_1089_104303400750001390 crossref_primary_10_1089_10430349950016799 crossref_primary_10_1016_S1525_0016_03_00022_4 crossref_primary_10_1038_sj_gt_3301710 crossref_primary_10_1128_CMR_17_2_370_389_2004 crossref_primary_10_1093_nar_gkt404 crossref_primary_10_1038_sj_gt_3302881 crossref_primary_10_1007_s11434_014_0197_6 crossref_primary_10_1089_10430340050032438 crossref_primary_10_1089_hum_2017_042 crossref_primary_10_1016_S0025_7125_02_00175_X crossref_primary_10_1101_pdb_prot5496 crossref_primary_10_1016_j_omtm_2018_01_002 crossref_primary_10_1016_j_virol_2005_02_008 crossref_primary_10_1038_sj_gt_3302615 crossref_primary_10_1016_j_biomaterials_2006_07_032 crossref_primary_10_1089_10430349950018427 crossref_primary_10_1097_00041433_200004000_00011 crossref_primary_10_1038_mt_2008_35 crossref_primary_10_1007_s10616_005_5361_z crossref_primary_10_1016_j_omtm_2023_08_002 crossref_primary_10_1046_j_1523_1755_2002_0610s1009_x crossref_primary_10_1016_S0958_1669_02_00369_5 crossref_primary_10_1016_j_jip_2011_05_008 crossref_primary_10_1016_j_ygyno_2006_06_020 crossref_primary_10_1634_theoncologist_7_1_46 crossref_primary_10_1128_JVI_75_1_375_383_2001 crossref_primary_10_5496_wjmg_v5_i3_28 crossref_primary_10_1016_S0166_2236_99_01539_8 crossref_primary_10_1038_35073500 crossref_primary_10_1128_JVI_76_4_1904_1913_2002 crossref_primary_10_1089_hgtb_2013_046 crossref_primary_10_1002_bit_20776 crossref_primary_10_1006_mthe_2002_0659 crossref_primary_10_1006_mthe_2001_0591 crossref_primary_10_1007_BF02253246 crossref_primary_10_1038_s41467_022_28738_2 crossref_primary_10_1128_JVI_76_24_13015_13027_2002 crossref_primary_10_3390_microorganisms12020384 crossref_primary_10_1006_mthe_2002_0695 crossref_primary_10_1038_gt_2008_61 crossref_primary_10_1128_JVI_79_17_10839_10851_2005 crossref_primary_10_1016_S1471_4914_02_02401_2 crossref_primary_10_1128_JVI_74_24_11511_11521_2000 crossref_primary_10_1002_1521_2254_200007_08_2_4_260__AID_JGM111_3_0_CO_2_8 |
Cites_doi | 10.1128/jvi.70.11.8098-8108.1996 10.1089/hum.1996.7.17-2079 10.1073/pnas.76.8.3665 10.1073/pnas.94.4.1426 10.1073/pnas.90.22.10613 10.1089/hum.1998.9.5-695 10.1128/JVI.72.3.2224-2232.1998 10.1073/pnas.55.6.1467 10.1128/jvi.71.7.5236-5243.1997 10.1126/science.149.3685.754 10.1128/jvi.71.11.8437-8447.1997 10.1073/pnas.94.13.6916 10.1089/hum.1997.8.6-659 10.1128/jvi.71.3.1897-1905.1997 10.1073/pnas.93.24.14082 10.1038/ng1094-148 10.1038/ng0797-270 10.1128/jvi.71.2.1341-1352.1997 10.1016/0042-6822(85)90243-0 10.1038/nm0397-306 10.1089/hum.1995.6.10-1329 10.1128/jvi.40.1.241-247.1981 10.1128/jvi.71.2.1140-1146.1997 10.1128/jvi.71.2.1079-1088.1997 10.1128/jvi.71.9.6816-6822.1997 |
ContentType | Journal Article |
Copyright | 1999 INIST-CNRS Macmillan Publishers Limited 1999. |
Copyright_xml | – notice: 1999 INIST-CNRS – notice: Macmillan Publishers Limited 1999. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7TK 7TM 7U9 8FD FR3 H94 K9. P64 RC3 7QO 7X8 |
DOI | 10.1038/sj.gt.3300807 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts Biotechnology Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Biotechnology Research Abstracts MEDLINE - Academic |
DatabaseTitleList | Engineering Research Database MEDLINE - Academic MEDLINE Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-5462 |
EndPage | 299 |
ExternalDocumentID | 10_1038_sj_gt_3300807 10435114 1721166 |
Genre | Journal Article |
GroupedDBID | --- -Q- .55 .GJ 0R~ 29H 2WC 36B 39C 3V. 4.4 406 53G 5GY 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AADWK AANZL AAPBV AATNV AAUGY AAWBL AAYFA AAYJO AAZLF ABAWZ ABDBF ABLJU ABPTK ABUWG ACBMV ACBRV ACBYP ACGFS ACIGE ACKTT ACPRK ACRQY ACTTH ACVWB ADBBV ADFRT ADHDB ADMDM ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AEVLU AEXYK AFKRA AFNRJ AFSHS AGAYW AGEZK AGGBP AGHAI AHGBK AHMBA AHSBF AILAN AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HZ~ IAO IEA IGG IHR IHW INH INR IQODW ISR ITC IWAJR JSO JZLTJ KQ8 LK8 M1P M2O M7P N9A NAO NQJWS NYICJ O9- OK1 OVD PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP W2D X7M Y6R ZA5 ~8M AACDK AASML AAYZH ABAKF ABJNI ABZZP ACAOD ACMJI ACZOJ AEFQL AEMSY AFBBN AGQEE AIGIU ALIPV CGR CUY CVF ECM EIF FIGPU HMCUK HVGLF NPM AAYXX CITATION 7QP 7TK 7TM 7U9 8FD FR3 H94 K9. P64 RC3 7QO 7X8 |
ID | FETCH-LOGICAL-c377t-44613a1364bb7a9279b24089d23ff2738ca2bf11aa453a0e9d150a2998b6c6763 |
ISSN | 0969-7128 |
IngestDate | Fri Aug 16 20:55:03 EDT 2024 Fri Aug 16 21:31:07 EDT 2024 Thu Oct 10 16:39:10 EDT 2024 Thu Sep 26 19:41:21 EDT 2024 Tue Oct 15 23:19:44 EDT 2024 Sun Oct 29 17:06:48 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Virus Human Associated virus Adenoviridae Cell line Recombinant virus Production Gene therapy Vector |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c377t-44613a1364bb7a9279b24089d23ff2738ca2bf11aa453a0e9d150a2998b6c6763 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 10435114 |
PQID | 2644624287 |
PQPubID | 34384 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_69939646 proquest_miscellaneous_17193796 proquest_journals_2644624287 crossref_primary_10_1038_sj_gt_3300807 pubmed_primary_10435114 pascalfrancis_primary_1721166 |
PublicationCentury | 1900 |
PublicationDate | 1999-02-01 |
PublicationDateYYYYMMDD | 1999-02-01 |
PublicationDate_xml | – month: 02 year: 1999 text: 1999-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: Houndmills |
PublicationTitle | Gene therapy |
PublicationTitleAlternate | Gene Ther |
PublicationYear | 1999 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | RM Buller (BF3300807_CR13) 1981; 40 KR Clark (BF3300807_CR18) 1995; 6 A Wistuba (BF3300807_CR22) 1997; 71 X Xiao (BF3300807_CR4) 1996; 70 KR Clark (BF3300807_CR17) 1996; 3 N Jones (BF3300807_CR24) 1979; 76 XS Wang (BF3300807_CR21) 1997; 71 MD Hoggan (BF3300807_CR12) 1966; 55 KA Vincent (BF3300807_CR19) 1997; 71 S Weger (BF3300807_CR23) 1997; 71 JM Allen (BF3300807_CR15) 1997; 71 TR Flotte (BF3300807_CR3) 1993; 90 PD Kessler (BF3300807_CR8) 1996; 93 A Salvetti (BF3300807_CR16) 1998; 9 MG Kaplitt (BF3300807_CR7) 1994; 8 JG Flannery (BF3300807_CR2) 1997; 94 DD Koeberl (BF3300807_CR6) 1997; 94 RO Snyder (BF3300807_CR9) 1997; 16 KR Clark (BF3300807_CR1) 1997; 8 DJ Pereira (BF3300807_CR25) 1997; 71 AJ Thrasher (BF3300807_CR26) 1995; 2 X Xiao (BF3300807_CR10) 1998; 72 J Li (BF3300807_CR20) 1997; 71 KJ Fisher (BF3300807_CR27) 1996; 7 RW Atchison (BF3300807_CR11) 1965; 149 KJ Fisher (BF3300807_CR5) 1997; 3 RA McPherson (BF3300807_CR14) 1985; 147 |
References_xml | – volume: 70 start-page: 8098 year: 1996 ident: BF3300807_CR4 publication-title: J Virol doi: 10.1128/jvi.70.11.8098-8108.1996 contributor: fullname: X Xiao – volume: 7 start-page: 2079 year: 1996 ident: BF3300807_CR27 publication-title: Hum Gene Ther doi: 10.1089/hum.1996.7.17-2079 contributor: fullname: KJ Fisher – volume: 3 start-page: 1124 year: 1996 ident: BF3300807_CR17 publication-title: Gene Therapy contributor: fullname: KR Clark – volume: 76 start-page: 3665 year: 1979 ident: BF3300807_CR24 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.76.8.3665 contributor: fullname: N Jones – volume: 94 start-page: 1426 year: 1997 ident: BF3300807_CR6 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.94.4.1426 contributor: fullname: DD Koeberl – volume: 90 start-page: 10613 year: 1993 ident: BF3300807_CR3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.90.22.10613 contributor: fullname: TR Flotte – volume: 9 start-page: 695 year: 1998 ident: BF3300807_CR16 publication-title: Hum Gene Ther doi: 10.1089/hum.1998.9.5-695 contributor: fullname: A Salvetti – volume: 72 start-page: 2224 year: 1998 ident: BF3300807_CR10 publication-title: J Virol doi: 10.1128/JVI.72.3.2224-2232.1998 contributor: fullname: X Xiao – volume: 55 start-page: 1457 year: 1966 ident: BF3300807_CR12 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.55.6.1467 contributor: fullname: MD Hoggan – volume: 71 start-page: 5236 year: 1997 ident: BF3300807_CR20 publication-title: J Virol doi: 10.1128/jvi.71.7.5236-5243.1997 contributor: fullname: J Li – volume: 149 start-page: 754 year: 1965 ident: BF3300807_CR11 publication-title: Science doi: 10.1126/science.149.3685.754 contributor: fullname: RW Atchison – volume: 71 start-page: 8437 year: 1997 ident: BF3300807_CR23 publication-title: J Virol doi: 10.1128/jvi.71.11.8437-8447.1997 contributor: fullname: S Weger – volume: 94 start-page: 6916 year: 1997 ident: BF3300807_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.94.13.6916 contributor: fullname: JG Flannery – volume: 8 start-page: 659 year: 1997 ident: BF3300807_CR1 publication-title: Hum Gene Ther doi: 10.1089/hum.1997.8.6-659 contributor: fullname: KR Clark – volume: 71 start-page: 1897 year: 1997 ident: BF3300807_CR19 publication-title: J Virol doi: 10.1128/jvi.71.3.1897-1905.1997 contributor: fullname: KA Vincent – volume: 93 start-page: 14082 year: 1996 ident: BF3300807_CR8 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.93.24.14082 contributor: fullname: PD Kessler – volume: 8 start-page: 148 year: 1994 ident: BF3300807_CR7 publication-title: Nat Genet doi: 10.1038/ng1094-148 contributor: fullname: MG Kaplitt – volume: 2 start-page: 481 year: 1995 ident: BF3300807_CR26 publication-title: Gene Therapy contributor: fullname: AJ Thrasher – volume: 16 start-page: 270 year: 1997 ident: BF3300807_CR9 publication-title: Nat Genet doi: 10.1038/ng0797-270 contributor: fullname: RO Snyder – volume: 71 start-page: 1341 year: 1997 ident: BF3300807_CR22 publication-title: J Virol doi: 10.1128/jvi.71.2.1341-1352.1997 contributor: fullname: A Wistuba – volume: 147 start-page: 217 year: 1985 ident: BF3300807_CR14 publication-title: Virology doi: 10.1016/0042-6822(85)90243-0 contributor: fullname: RA McPherson – volume: 3 start-page: 306 year: 1997 ident: BF3300807_CR5 publication-title: Nature Med doi: 10.1038/nm0397-306 contributor: fullname: KJ Fisher – volume: 6 start-page: 1329 year: 1995 ident: BF3300807_CR18 publication-title: Hum Gene Ther doi: 10.1089/hum.1995.6.10-1329 contributor: fullname: KR Clark – volume: 40 start-page: 241 year: 1981 ident: BF3300807_CR13 publication-title: J Virol doi: 10.1128/jvi.40.1.241-247.1981 contributor: fullname: RM Buller – volume: 71 start-page: 1140 year: 1997 ident: BF3300807_CR21 publication-title: J Virol doi: 10.1128/jvi.71.2.1140-1146.1997 contributor: fullname: XS Wang – volume: 71 start-page: 1079 year: 1997 ident: BF3300807_CR25 publication-title: J Virol doi: 10.1128/jvi.71.2.1079-1088.1997 contributor: fullname: DJ Pereira – volume: 71 start-page: 6816 year: 1997 ident: BF3300807_CR15 publication-title: J Virol doi: 10.1128/jvi.71.9.6816-6822.1997 contributor: fullname: JM Allen |
SSID | ssj0004782 |
Score | 1.89784 |
Snippet | Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 293 |
SubjectTerms | Adenoviridae - genetics Adenoviruses Biological and medical sciences Biotechnology Cell Line Dependovirus - genetics DNA, Recombinant Expression vectors Fundamental and applied biological sciences. Psychology Gene therapy Genetic Therapy - methods Genetic Vectors Genomes Health. Pharmaceutical industry Humans Industrial applications and implications. Economical aspects Packaging Plasmids Transfection Viruses |
Title | Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10435114 https://www.proquest.com/docview/2644624287 https://search.proquest.com/docview/17193796 https://search.proquest.com/docview/69939646 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagkxASQtwpbMMPiJcopYkdO37c0KoJdYWHVupbZOcyNkQ7LckE-_U7vuRSuonLS1Ql9mnk79j-jnMuCL2PxpkqFIn8gqfEp7SQvkgJ8fOxDFgkFWxpOnb4ZMaOF_TzMlo2tdpddEmlRun1rXEl_4Mq3ANcdZTsPyDbCoUb8BvwhSsgDNe_wvirTdfqOJ-2bX8o49niSVhO1r50Yw-k8urssi69q9xW16nNCYH0wGD-bssU6QN8z1BOk73V-_ZLh3JtyzRy-oxW5632qs3cBNOzWkO39NqTZeMGZBaVzkPRFecyPNbdzVw8nmg8lrtzRCZ8HrgIb7eksp7mhP3l0VZDdDttaEsjbS3iNmV7eT46rUaEaE7Lu92q-UI_-5JMFtNpMj9azu-jnZCLKBqgnYPJ4eGsC4zlplpY-44uySr8wccN8Ruk5NGFLGF-FLawyd2Wh2Eg8yfosTMd8IHVg6foXr56hh6cOOeI5-hnpw54XeAedPh3dcAGRuzUARt1wBK36oC1OmCtDhjUAZ5YddiWaeS8QIvJ0fzTse8Ka_gp4byCKQkkTgaEUaW4FDB2Sme6E1lIikLHaqUyVEUQSEkjIse5yMBskABXrFjKYEd6iQar9Sp_jXDIGSvoWORhmNI0ViAjExmPMl04IY7zIfrQjGxyYfOnJMbvgcRJeZ6cVomDYIj2Nsa9a63PKBgbot0Gh8RNwTLRbF4HOMXQ_V37GBZIPUpyla_rEvqDjcIFu7sFA44uGIUWryy-vTel-kM7ffPHvm_Rw2527KJBdVnne0BXK7XvlPIGydSa8g |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Production+of+recombinant+adeno-associated+virus+vectors+using+a+packaging+cell+line+and+a+hybrid+recombinant+adenovirus&rft.jtitle=Gene+therapy&rft.au=Liu%2C+X+L&rft.au=Clark%2C+K+R&rft.au=Johnson%2C+P+R&rft.date=1999-02-01&rft.issn=0969-7128&rft.volume=6&rft.issue=2&rft.spage=293&rft.epage=299&rft_id=info:doi/10.1038%2Fsj.gt.3300807&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-7128&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-7128&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-7128&client=summon |